UPDATE 1-Fresenius nudges up Kabi earnings guidance

Fresenius SE nudged up its earnings guidance for its Kabi generic drugs unit on Tuesday after it was boosted by a European ruling not to ban HES medicines.

from Reuters: Company News https://ift.tt/2LPZKUd
via IFTTT